Medicare Enrolled
Dr. Anthony Maniscalco, M.D.
Neurology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maniscalco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maniscalco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maniscalco
Dr. Anthony Maniscalco is a neurology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Maniscalco performed 1,225 Medicare services across 1,065 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maniscalco received a total of $6,648 from 58 pharmaceutical and/or device companies across 306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maniscalco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NY
$6,648 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,225
Medicare services
Top 25% in NY for neurology
1,065
Unique beneficiaries
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $93 | $240 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
172 | $71 | $170 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $83 | $220 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
147 | $148 | $460 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
115 | $120 | $310 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
80 | $105 | $235 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
54 | $260 | $640 |
| New patient office visit, complex (60-74 min) | 48 | $174 | $540 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $153 | $410 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
33 | $423 | $1,120 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
27 | $364 | $930 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
19 | $87 | $250 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
19 | $229 | $610 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
17 | $100 | $220 |
| Ultrasound of head and neck blood flow, one side An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels on one side of the head and neck. |
13 | $108 | $330 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $132 | $440 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,648
Total received (2018-2024)
Avg $950/year across 7 years
Top 29% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
306
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,567 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,325
2023
$894
2022
$785
2021
$984
2020
$715
2019
$890
2018
$1,055
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$281
ACADIA Pharmaceuticals Inc
$181
ABBVIE INC.
$123
Amneal Pharmaceuticals LLC
$95
Lilly USA, LLC
$90
Otsuka America Pharmaceutical, Inc.
$73
UCB, Inc.
$69
Alexion Pharmaceuticals, Inc.
$48
Medtronic, Inc.
$47
PFIZER INC.
$41
Lundbeck LLC
$40
Amgen Inc.
$38
Neurocrine Biosciences, Inc.
$31
Biogen, Inc.
$28
ARGENX US, INC.
$27
Alnylam Pharmaceuticals Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
Corium, LLC
$22
Marinus Pharmaceuticals, Inc.
$22
Eisai Inc.
$21
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$549
ACADIA Pharmaceuticals Inc
$410
Amgen Inc.
$391
Lilly USA, LLC
$369
EMD Serono, Inc.
$355
Alexion Pharmaceuticals, Inc.
$300
PFIZER INC.
$297
ABBVIE INC.
$281
Biogen, Inc.
$275
AbbVie Inc.
$207
Neurocrine Biosciences, Inc.
$200
Avanir Pharmaceuticals, Inc.
$179
Amneal Pharmaceuticals LLC
$164
GENZYME CORPORATION
$163
Teva Pharmaceuticals USA, Inc.
$156
Sunovion Pharmaceuticals Inc.
$145
Genentech USA, Inc.
$125
Allergan, Inc.
$120
Novartis Pharmaceuticals Corporation
$117
Otsuka America Pharmaceutical, Inc.
$115
Penumbra, Inc.
$113
Lundbeck LLC
$105
ARGENX US, INC.
$101
GE HEALTHCARE
$94
Abbott Laboratories
$92
Celgene Corporation
$87
Stryker Corporation
$82
Avion Pharmaceuticals
$82
Acorda Therapeutics, Inc
$80
US WorldMeds, LLC
$79
Allergan Inc.
$67
MDD US Operations, LLC
$59
E.R. Squibb & Sons, L.L.C.
$47
Medtronic, Inc.
$47
Janssen Pharmaceuticals, Inc
$47
Eisai Inc.
$43
Grifols USA, LLC
$41
Adamas Pharmaceuticals, Inc.
$41
SK Life Science, Inc.
$36
Mallinckrodt Hospital Products Inc.
$30
Vertical Pharmaceuticals, LLC
$25
Alnylam Pharmaceuticals Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
Boston Scientific Corporation
$23
Neurelis, Inc.
$23
Strongbridge US INC.
$23
Corium, LLC
$22
Marinus Pharmaceuticals, Inc.
$22
Alfasigma USA, Inc.
$21
UPSHER-SMITH LABORATORIES LLC
$20
Scilex Pharmaceuticals Inc.
$20
Biohaven Pharmaceutical Holding Company Ltd.
$18
Merck Sharp & Dohme Corporation
$18
Bausch Health US, LLC
$17
Horizon Therapeutics plc
$17
Aprecia Pharmaceuticals, LLC
$15
ARBOR PHARMACEUTICALS, INC.
$14
Supernus Pharmaceuticals, Inc.
$12
Top 3 companies account for 20.3% of all-time payments
Associated products mentioned in payments ›
ACE · ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Activase · Aimovig · Austedo XR · Azstarys · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · CREXONT · DUOPA · Dhivy · EMGALITY · Fycompa · GENERAL DBS · GOCOVRI · Gamunex-C · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · PIPELINE · Pacemakers · QULIPTA · RELEXXII · REXULTI · RYTARY · SOLIRIS · Soliris · Spritam · TOSYMRA · TREVO · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · Xadago · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,214
Per 100K population
45.9
County median income
$78,548
Nearest hospital
VA NEW YORK HARBOR HEALTHCARE SYSTEM - BROOKLYN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maniscalco is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maniscalco experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maniscalco performed 265 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maniscalco receive payments from pharmaceutical companies?
Yes. Dr. Maniscalco received a total of $6,648 from 58 companies across 306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maniscalco's costs compare to other neurologists in Brooklyn?
Dr. Maniscalco's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maniscalco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Brooklyn
Browse neurologists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology